Search results
Results from the WOW.Com Content Network
Hematidrosis, also called hematohidrosis, haematidrosis, hemidrosis and blood sweat, is a very rare condition in which a human sweats blood. [1] The term is from Ancient Greek haîma / haímatos ( αἷμα / αἵματος ), meaning blood, and hīdrṓs ( ἱδρώς ), meaning sweat.
Typical treatment for chronic iron overload requires subcutaneous injection over a period of 8–12 hours daily. [ citation needed ] Two newer iron-chelating drugs that are licensed for use in patients receiving regular blood transfusions to treat thalassaemia (and, thus, who develop iron overload as a result) are deferasirox and deferiprone .
Treatment for hemosiderin focuses on limiting the effects of the underlying disease leading to continued deposition. In hemochromatosis, this entails frequent phlebotomy granulomatosis, immune suppression is required.
Management of ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) focuses on symptoms management, as no treatments that address the root cause of the illness are available. [ 1 ] : 29 Pacing, or regulating one's activities to avoid triggering worse symptoms, is the most common management strategy for post-exertional malaise .
Diphenhydramine, sold under the brand name Benadryl among others, is an antihistamine and sedative.It is a first-generation H 1-antihistamine and it works by blocking certain effects of histamine, which produces its antihistamine and sedative effects.
Rilmenidine, an oxazoline compound with antihypertensive properties, acts on both medullary and peripheral vasomotor structures.. Rilmenidine is a imidazoline analog and shows greater selectivity for imidazoline receptors than for cerebral alpha2-adrenergic receptors, distinguishing it from reference alpha2-agonists, and conferring additional anti-inflammatory actions not shared with most ...
For cases related to genetic hair loss, two commonly prescribed and FDA-approved treatments are minoxidil (a topical solution) and finasteride (an oral medication for men). These treatments have ...
Once a diagnosis is made, the treatment is based on an individual's clinical condition. Kurolap and colleagues treated patients with off-label eculizumab , a humanized anti-C5 monoclonal antibody and complement inhibitor, and it was shown to have beneficial outcomes over an 18-month period. [ 6 ]